Andrew Schorr

140 Articles

With Imbruvica (Ibrutinib) Approval CLL Options Accelerating

This week the US Food and Drug Administration (FDA), as expected, approved…

Andrew Schorr Andrew Schorr

It’s Counterintuitive: Cancer and Laughter

Dr. Michael Keating and CLL Patient Shari Brenner who brings him a…

Andrew Schorr Andrew Schorr

Patient’s Urgent and Ongoing Search for Cancer Information

As we have written many times here, the pace of research and…

Andrew Schorr Andrew Schorr

2014: A Year of More Answers to Your Questions About Cancer

So often articles, programs and classes about serious illnesses talk AT you.…

Andrew Schorr Andrew Schorr

Optimism and Changes Ahead for Blood Cancer Patients [VIDEO]

Changes impacting the treatment landscape in many blood cancers were discussed this…

Andrew Schorr Andrew Schorr

When High Hopes for New Cancer Drugs Are In Limbo

There was tremendous excitement last year at the American Society of Hematology…

Andrew Schorr Andrew Schorr

Understanding Cancer: It’s Getting More Complicated

A diagnosis of cancer is the last thing anyone wants to hear.…

Andrew Schorr Andrew Schorr

Our Doctors Are Excited – Maybe We Should Be Excited, Too

Dr. Neil Kay from the Mayo Clinic discusses advances in CLL treatment…

Andrew Schorr Andrew Schorr

Is a Daily Dose of Many Pills in Your Future?

In the hustle and bustle of our daily lives we don’t tend…

Andrew Schorr Andrew Schorr

Can We Lower the Risk of Second Cancers?

Linda Lewis, former editor of More and Today’s Parent magazines, Canada. (Photo credit:…

Andrew Schorr Andrew Schorr